SYRA · Syra Health Corp
Market Cap
$10.79M
Shares
13.84M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$7.23M
-9.5%
FY2025
Net Income
-$896.33K
+76.2%
FY2025
Gross Margin
34.43%
+13.7pp
FY2025
Operating Margin
-12.51%
+34.7pp
FY2025
Diluted EPS
-$0.08
+84%
FY2025
Operating Cash Flow
-$447.75K
+84.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| $8.09M | $7.23M | $7.98M | $5.52M | $5.62M | |
| $4.91M | $4.74M | $6.33M | $4.1M | $4.56M | |
| $3.18M | $2.49M | $1.65M | $1.41M | $1.06M | |
| — | 34.43% | 20.71% | 25.6% | 18.9% | |
| $55.23K | $67.84K | $585.15K | $240.05K | — | |
| $938.55K | $1.07M | $1.45M | $1.13M | $575.76K | |
| $3.11M | $3.39M | $5.42M | $4.3M | $3.15M | |
| $74.72K | -$904.32K | -$3.76M | -$2.89M | -$2.09M | |
| — | -12.51% | -47.17% | -52.36% | -37.2% | |
| $10.86K | $13.27K | $15.6K | $53.69K | $28.53K | |
| $66.89K | $21.26K | $21.25K | $2942 | $63 | |
| $56.03K | $7991 | $5647 | -$50.74K | -$28.47K | |
| $130.75K | -$896.33K | -$3.76M | -$2.94M | -$2.12M | |
| — | -12.4% | -47.1% | -53.28% | -37.71% | |
| USD/shares | $0.01 | -$0.08 | -$0.50 | -$0.60 | -$0.70 |
| USD/shares | $0.01 | -$0.08 | -$0.50 | -$0.60 | -$0.70 |
| shares | — | 11.85M | 7.55M | 4.88M | 3.04M |
| shares | — | 11.85M | 7.55M | 4.88M | 3.04M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 0.78×
EV/EBIT
—
P/E (TTM)
78.00×
Peer medians compare against the 12 similar-size Medical Care Facilities companies (of 53 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Population Health | $5,323,273 | $2,068,804 | $715,499 | $318,036 |
| Healthcare Workforce | $1,902,700 | $5,896,433 | $4,259,292 | $5,260,370 |
| Behavioral and Mental Health | — | $16,845 | — | — |
| Behavioral and Mental Services | — | — | $12,797 | — |
| Digital Health | — | — | $515,250 | — |
| Health Education | — | — | $12,306 | $39,300 |